These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 8821213)

  • 21. Factor VIIa and antithrombin III activity during severe sepsis and septic shock in neutropenic patients.
    Mesters RM; Mannucci PM; Coppola R; Keller T; Ostermann H; Kienast J
    Blood; 1996 Aug; 88(3):881-6. PubMed ID: 8704245
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Therapeutic modalities to ameliorate endotoxin induced DIC in the rats.
    Bahrami S; Paul E; Redl H; Schlag G
    Prog Clin Biol Res; 1989; 308():977-82. PubMed ID: 2780743
    [No Abstract]   [Full Text] [Related]  

  • 23. Serum albumin levels anticipate antithrombin III activities before and after antithrombin III agent in critical patients with disseminated intravascular coagulation.
    Aibiki M; Fukuoka N; Umakoshi K; Ohtsubo S; Kikuchi S
    Shock; 2007 Feb; 27(2):139-44. PubMed ID: 17224787
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical utility of prothrombin fragment 1+2, thrombin antithrombin III complexes and D-dimer measurements in the diagnosis of deep vein thrombosis following total hip replacement.
    Cofrancesco E; Cortellaro M; Corradi A; Ravasi F; Bertocchi F
    Thromb Haemost; 1998 Mar; 79(3):509-10. PubMed ID: 9531030
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Assay for activity of heparin-antithrombin III complex during treatment of DIC with heparin and its clinical significance].
    Tomihara T; Shimazu C; Yasuda K; Kazama M; Abe T
    Rinsho Byori; 1986 Feb; 34(2):179-84. PubMed ID: 3702087
    [No Abstract]   [Full Text] [Related]  

  • 26. Severe antithrombin III deficiency in a patient with pre-eclampsia. Observations on the effect of human AT III concentrate transfusion.
    Büller HR; Weenink AH; Treffers PE; Kahlé LH; Otten HA; ten Cate JW
    Scand J Haematol; 1980 Jul; 25(1):81-6. PubMed ID: 7444377
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Thrombin-antithrombin III and prothrombin fragment 1.2 levels in early respiratory distress syndrome.
    Yurdakök M; Yigit S; Gürakan B; Dündar S; Kirazli S
    Am J Hematol; 1996 Mar; 51(3):247-8. PubMed ID: 8619412
    [No Abstract]   [Full Text] [Related]  

  • 28. [Place of antithrombin III concentrate in the intensive care of disseminated intravascular coagulation].
    Vorob'eva NA; Neporada EL; Turundaevskaia OV; Mel'nikova GN
    Anesteziol Reanimatol; 2007; (2):42-4. PubMed ID: 17563999
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Preliminary study for the evaluation of the feasibility of a multicenter clinical trial for the evaluation of the therapeutic efficacy of an antithrombin III concentration (Immuno) in the intravascular coagulation syndrome].
    Palareti G; Legnani C; Ludovici S; Maccaferri M
    Haematologica; 1990; 75 Suppl 2():21-32. PubMed ID: 2201605
    [No Abstract]   [Full Text] [Related]  

  • 30. [Decreased endothelial antithrombogenic activity in disseminated intravascular coagulation].
    Tsukasato T; Maruyama Y; Maruyama I
    Rinsho Ketsueki; 1987 Dec; 28(12):2110-6. PubMed ID: 2968472
    [No Abstract]   [Full Text] [Related]  

  • 31. [Heparin, low molecular weight heparin, heparinoid, and antithrombin III therapy of disseminated intravascular coagulation].
    Nakagawa M
    Nihon Rinsho; 1993 Jan; 51(1):87-92. PubMed ID: 7679453
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recombinant human antithrombin III restores heparin responsiveness and decreases activation of coagulation in heparin-resistant patients during cardiopulmonary bypass.
    Avidan MS; Levy JH; van Aken H; Feneck RO; Latimer RD; Ott E; Martin E; Birnbaum DE; Bonfiglio LJ; Kajdasz DK; Despotis GJ
    J Thorac Cardiovasc Surg; 2005 Jul; 130(1):107-13. PubMed ID: 15999048
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Therapeutic use of antithrombin III in shock and disseminated intravascular coagulation.
    Vinazzer H
    Semin Thromb Hemost; 1989 Jul; 15(3):347-52. PubMed ID: 2688106
    [No Abstract]   [Full Text] [Related]  

  • 34. [Thrombophilic conditions and their clinical aspects].
    Bokarev IN
    Klin Med (Mosk); 1991 Aug; 69(8):11-7. PubMed ID: 1791699
    [No Abstract]   [Full Text] [Related]  

  • 35. [Antithrombin III and heparin].
    Zhu KC
    Zhonghua Fu Chan Ke Za Zhi; 1988 May; 23(3):177-9. PubMed ID: 3058418
    [No Abstract]   [Full Text] [Related]  

  • 36. The role of antithrombin III in the perioperative management of the patient with unstable angina.
    Rossi M; Martinelli L; Storti S; Corrado M; Marra R; Varano C; Schiavello R
    Ann Thorac Surg; 1999 Dec; 68(6):2231-6. PubMed ID: 10617008
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Therapy of disseminated intravascular coagulation].
    Matsuda T
    Rinsho Byori; 1985 Jun; Spec No 63():79-89. PubMed ID: 3930817
    [No Abstract]   [Full Text] [Related]  

  • 38. Existence of a hypercoagulability state prior to prosthetic hip or knee surgery.
    Iturbe T; Cornudella R; de Miguel R; Olave T; Moreno JA; Gutiérrez M
    Haematologica; 1999 Jan; 84(1):87-8. PubMed ID: 10091398
    [No Abstract]   [Full Text] [Related]  

  • 39. [Molecular markers of hemostatic mechanisms--thrombin-antithrombin III complex].
    Fukutake K
    Rinsho Byori; 1989 Mar; 37(3):261-5. PubMed ID: 2664281
    [No Abstract]   [Full Text] [Related]  

  • 40. [Clinical aspects of acquired antithrombin III deficiency].
    von Blohn G; Hellstern P; Köhler M; Scheffler P; Wenzel E
    Behring Inst Mitt; 1986 Feb; (79):200-15. PubMed ID: 3718407
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.